NANO MRNA CO LTDNANO MRNA CO LTDNANO MRNA CO LTD

NANO MRNA CO LTD

No trades
See on Supercharts

4571 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
4571 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company